Use of antimicrobials in pediatric wards of five Brazilian hospitals

Thais de Barros Fernandes1, Sheila Feitosa Ramos2, Luísa Rodrigues Furtado Leitzke3

  • 1Sergio Arouca National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, 21041-210, Brazil. fernandes.thaisb@gmail.com.

BMC Pediatrics
|March 14, 2024
PubMed

Insights

Antimicrobial use in hospitalized children in Brazil is high and varies significantly between hospitals, with frequent off-label prescribing, particularly for azithromycin. This highlights a need for improved antimicrobial stewardship in pediatric care.

Area of Science:

  • Pediatric Infectious Diseases
  • Pharmacology and Therapeutics
  • Public Health and Epidemiology

Background:

  • Antimicrobial (AM) use in children is common, yet inappropriate use contributes to antimicrobial resistance.
  • Off-label (OL) antimicrobial prescribing is prevalent in pediatric populations, increasing the risk of drug-related problems.
  • There is a notable lack of drug utilization review (DUR) data for pediatric antimicrobial use in Brazil and Latin America.

Purpose of the Study:

  • To characterize antimicrobial utilization patterns in hospitalized children across five Brazilian hospitals.
  • To assess the extent and characteristics of off-label antimicrobial use in this pediatric cohort.
  • To identify variations in antimicrobial prescribing and identify factors associated with off-label use.

Main Methods:

  • An observational study was conducted in pediatric wards of five hospitals in Brazil (CE, SE, RJ, RS, DF).
  • Data on antimicrobial use were collected from patient medical records and prescriptions over a six-month period per hospital.
  • Antimicrobial utilization was quantified using Days of Therapy (DOT) and Length of Therapy (LOT) per 1000 patient days, with off-label use analyzed by age.

Main Results:

  • Data from 1020 pediatric patients were analyzed, revealing significant variations in DOT/1000PD (278-517) and LOT/1000PD (265-390) across hospitals.
  • Respiratory tract infections were the most common indication for antimicrobial use. Antimicrobial utilization was highest in the Sergipe (SE) hospital.
  • Off-label use was more prevalent in the Rio de Janeiro (RJ) hospital, infants, patients with prolonged stays, and those receiving multiple antimicrobials. Azithromycin showed the highest OL prevalence.

Conclusions:

  • Overall antimicrobial use in hospitalized children in Brazil is high and exhibits considerable inter-hospital variability, influenced by local factors and prescribing habits.
  • Off-label prescribing is a significant concern, particularly for specific antimicrobials like azithromycin and in certain patient subgroups.
  • Findings underscore the need for enhanced antimicrobial stewardship programs and DUR initiatives in Brazilian pediatric healthcare settings.